FdaApplication
ANDA 216969
Identifiers
- fda_app_no: ANDA216969
Properties
| Property | Value |
|---|---|
| applicant_name | ALEMBIC PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2023-09-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE | 5MG;2.5MG | CAPSULE;ORAL |
1 product